Queens Hospital Center, Jamaica
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Stony Brook University Medical Center, Stony Brook

Тражи се учесникОпсервациона студијаЗдраве особе су добродошле

Узраст од 40 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT05334069

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

Roswell Park Comprehensive Cancer Center, Buffalo
Memorial Sloan Kettering Cancer Center, New York
New York Presbyterian - Weill Cornell, New York
и још 2

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT06852222

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

Memorial Sloan Kettering Commack, Commack
Memorial Sloan Kettering Westchester, Harrison
Memorial Sloan Kettering Cancer Center, New York
и још 1

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT06484062

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Roswell Park Cancer Institute, Buffalo
Memorial Sloan Kettering Commack, Commack
Northwell Health/Center for Advanced Medicine, Lake Success
и још 9

Тражи се учесникФаза 2

Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT05564390

Phase 1 Open-label Study of AMX-883 Alone in Participants With AML and High-risk MDS and in Combination in Participants With AML

Memorial Sloan-Kettering Cancer Center - Hematology Service MSKCC, New York

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT07723703

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

University of Rochester Medical Center (URMC), Rochester

Тражи се учесникФаза 3

Узраст од 18 до 75 · Оба пола · Ажурирано 30. 10. 2026. · NCT05429632

Study of REM-422 in Patients With AML or Higher Risk MDS

Memorial Sloan Kettering, New York

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT06297941

CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Roswell Park Cancer Institute, Buffalo
New York University, New York
New York-Presbyterian / Weill Cornell Medical Center, New York

Тражи се учесникФаза 1/2

Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT05143996

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Roswell Park Cancer Institute, Buffalo
Memorial Sloan Kettering Commack, Commack
Mount Sinai Hospital, New York
и још 5

Тражи се учесникФаза 2

Узраст од 18 до 59 · Оба пола · Ажурирано 28. 10. 2026. · NCT05554393

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Roswell Park Cancer Institute, Buffalo
Memorial Sloan Kettering Commack, Commack
Memorial Sloan Kettering Westchester, Harrison
и још 5

Тражи се учесникФаза 2

Узраст 18 и старији · Оба пола · Ажурирано 27. 10. 2026. · NCT06672146

Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Roswell Park Cancer Institute, Buffalo

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 27. 10. 2026. · NCT06871410

Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression

Research Site, New York

Тражи се учесникФаза 1/2

Узраст 16 и старији · Оба пола · Ажурирано 23. 10. 2026. · NCT07155226

A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)

Roswell Park Comprehensive Cancer Center, Buffalo

Тражи се учесникФаза 1/2

Узраст 18 и старији · Оба пола · Ажурирано 23. 10. 2026. · NCT06969430

A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia

Memorial Sloan Kettering Cancer Center, New York

Тражи се учесникФаза 1

До 21 година · Оба пола · Ажурирано 23. 10. 2026. · NCT07012044

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

Memorial Sloan- Kettering Cancer Center, New York

Тражи се учесникФаза 1

Узраст од 1 до 30 · Оба пола · Ажурирано 22. 10. 2026. · NCT06177067

A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)

Montefiore Medical Center - Moses Campus /ID# 279399, The Bronx

Тражи се учесникФаза 2/3

Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT07581002

Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML/HR-MDS and in Combination With Azacitidine in Previously Untreated HR-MDS

Memorial Sloan Kettering Cancer Center, New York
Montefiore Medical Center, New York

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 20. 10. 2026. · NCT06533761

A Study of Revumenib and Mezigdomide in People With Leukemia

Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
и још 1

Тражи се учесникФаза 1/2

Узраст 12 и старији · Оба пола · Ажурирано 20. 10. 2026. · NCT07356154

Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS

Roswell Park Comprehensive Cancer Center, Buffalo
Memorial Sloan Kettering Cancer Center, New York

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 16. 10. 2026. · NCT06846606

Danvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed/Refractory MDS & AML

Montefiore Medical Center, The Bronx

Тражи се учесникФаза 1Здраве особе су добродошле

Узраст 18 и старији · Оба пола · Ажурирано 15. 10. 2026. · NCT05986240

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

Montefiore Medical Center, New York

Тражи се учесникФаза 1/2

30 Days · Оба пола · Ажурирано 9. 10. 2026. · NCT04065399

A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies

University of Rochester, Rochester

Тражи се учесникОпсервациона студија

Узраст 0 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT07154823

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Roswell Park Comprehensive Cancer Center, Buffalo
New York University Langone Hospital - Long Island, Mineola
Perlmutter Cancer Center - 34th Street, New York
и још 2

Тражи се учесникФаза 2/3

Узраст 18 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT04256317

A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia

Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All protocol activites), New York
и још 1

Тражи се учесникФаза 1

Узраст 1 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT06017258

A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia

Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
и још 1

Тражи се учесникФаза 2

Узраст 60 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT07392242

A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

New York Medical College /ID# 275597, Valhalla

Тражи се учесникФаза 1

6 Months – 17 Years · Оба пола · Ажурирано 5. 10. 2026. · NCT07306832

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Memorial Sloan Kettering Cancer Center, New York

Тражи се учесникФаза 1

Узраст од 12 до 78 · Оба пола · Ажурирано 29. 9. 2026. · NCT03802695

A Multi-Site Break Through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and Revumenib

Memorial Sloan Kettering Cancer Center, New York

Тражи се учесникФаза 1/2

Узраст 12 и старији · Оба пола · Ажурирано 18. 9. 2026. · NCT06284486

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Albany Medical Center, Albany
Maimonides Medical Center, Brooklyn
Roswell Park Cancer Institute, Buffalo
и још 11

Тражи се учесникФаза 3

6 Months – 21 Years · Оба пола · Ажурирано 17. 9. 2026. · NCT04293562

Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

Weill Cornell, New York
Clinical Research Allicance, Westbury

Тражи се учесникФаза 2

Узраст 18 и старији · Оба пола · Ажурирано 16. 9. 2026. · NCT06824168

A Telehealth Advance Care Planning Intervention

University of Rochester, Rochester

Тражи се учесник

Узраст 60 и старији · Оба пола · Ажурирано 11. 9. 2026. · NCT05875805

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

Albany Medical Center, Albany
Montefiore Medical Center - Moses Campus, The Bronx

Тражи се учесникФаза 3

Узраст од 1 до 25 · Оба пола · Ажурирано 4. 9. 2026. · NCT07022678

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Albany Medical Center, Albany
Maimonides Medical Center, Brooklyn
NYU Langone Hospital - Long Island, Mineola
и још 7

Тражи се учесникФаза 1/2

До 22 година · Оба пола · Ажурирано 25. 8. 2026. · NCT04726241

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.